QL
NVAX icon

Quarry LP’s Novavax NVAX Stock Holding History

Quarry LP’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,772
Closed -$32.7K – 2467
2025
Q3 		$32.7K Buy
+3,772
New +$29.4K 0.01% 1106

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quarry LP's NVAX Position: Q4 2025 in Review

Quarry LP sold out of Novavax (NVAX) in Q4 2025, closing a stake of 3,772 shares — an estimated $32.7K sold.

Quarry LP first reported a position in NVAX in Q3 2025 and held it in 1 quarter. The position peaked at $32.7K in Q3 2025. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Quarry LP reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Quarry LP sold 3,772 Novavax shares in Q4 2025, an estimated $32.7K.
  • Quarry LP first reported a position in Novavax in Q3 2025 and held it in 1 quarter.
  • Quarry LP's Novavax position peaked at $32.7K in Q3 2025.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.